AAAAAA

   
Results: 1-15 |
Results: 15
A SEROLOGIC STUDY OF ORGANISMS POSSIBLY ASSOCIATED WITH PERTUSSIS-LIKE COUGHING
Authors: VONKONIG CHW ROTT H BOGAERTS H SCHMITT HJ
Citation: Chw. Vonkonig et al., A SEROLOGIC STUDY OF ORGANISMS POSSIBLY ASSOCIATED WITH PERTUSSIS-LIKE COUGHING, The Pediatric infectious disease journal, 17(7), 1998, pp. 645-649
FACTORS INFLUENCING THE SPREAD OF PERTUSSIS IN HOUSEHOLDS
Authors: VONKONIG CHW POSTELSMULTANI S BOGAERTS H BOCK HL LAUKAMP S KIEDERLE S SCHMITT HJ
Citation: Chw. Vonkonig et al., FACTORS INFLUENCING THE SPREAD OF PERTUSSIS IN HOUSEHOLDS, European journal of pediatrics, 157(5), 1998, pp. 391-394
IMMUNOGENICITY AND REACTOGENICITY OF A HAEMOPHILUS-INFLUENZAE TYPE-B TETANUS CONJUGATE VACCINE WHEN ADMINISTERED SEPARATELY OR MIXED WITH CONCOMITANT DIPHTHERIA-TETANUS-TOXOID AND ACELLULAR PERTUSSIS-VACCINE FOR PRIMARY AND FOR BOOSTER IMMUNIZATIONS
Authors: SCHMITT HJ ZEPP F MUSCHENBORN S SUMENICHT G SCHUIND A BEUTEL K KNUF M BOCK HL BOGAERTS H CLEMENS R
Citation: Hj. Schmitt et al., IMMUNOGENICITY AND REACTOGENICITY OF A HAEMOPHILUS-INFLUENZAE TYPE-B TETANUS CONJUGATE VACCINE WHEN ADMINISTERED SEPARATELY OR MIXED WITH CONCOMITANT DIPHTHERIA-TETANUS-TOXOID AND ACELLULAR PERTUSSIS-VACCINE FOR PRIMARY AND FOR BOOSTER IMMUNIZATIONS, European journal of pediatrics, 157(3), 1998, pp. 208-214
EVIDENCE FOR INDUCTION OF POLYSACCHARIDE SPECIFIC B-CELL-MEMORY IN THE 1ST YEAR OF LIFE - PLAIN HAEMOPHILUS-INFLUENZAE TYPE-B - PRP (HIB) BOOSTERS CHILDREN PRIMED WITH A TETANUS-CONJUGATE HIB-DTPA-HBV COMBINEDVACCINE
Authors: ZEPP F SCHMITT HJ KAUFHOLD A SCHUIND A KNUF M HABERMEHL P MEYER C BOGAERTS H SLAOUI M CLEMENS R
Citation: F. Zepp et al., EVIDENCE FOR INDUCTION OF POLYSACCHARIDE SPECIFIC B-CELL-MEMORY IN THE 1ST YEAR OF LIFE - PLAIN HAEMOPHILUS-INFLUENZAE TYPE-B - PRP (HIB) BOOSTERS CHILDREN PRIMED WITH A TETANUS-CONJUGATE HIB-DTPA-HBV COMBINEDVACCINE, European journal of pediatrics, 156(1), 1997, pp. 18-24
REACTOGENICITY AND IMMUNOGENICITY OF A BOOSTER DOSE OF A COMBINED DIPHTHERIA, TETANUS, AND TRICOMPONENT ACELLULAR PERTUSSIS-VACCINE AT 14 TO 28 MONTHS OF AGE
Authors: SCHMITT HJ BEUTEL K SCHUIND A KNUF M WAGNER S MUSCHENBORN S BOGAERTS H BOCK HL CLEMENS R
Citation: Hj. Schmitt et al., REACTOGENICITY AND IMMUNOGENICITY OF A BOOSTER DOSE OF A COMBINED DIPHTHERIA, TETANUS, AND TRICOMPONENT ACELLULAR PERTUSSIS-VACCINE AT 14 TO 28 MONTHS OF AGE, The Journal of pediatrics, 130(4), 1997, pp. 616-623
EFFICACY OF ACELLULAR PERTUSSIS-VACCINE IN EARLY-CHILDHOOD AFTER HOUSEHOLD EXPOSURE
Authors: SCHMITT HJ VONKONIG CHW NEISS A BOGAERTS H BOCK HL SCHULTEWISSERMANN H GAHR M SCHULT R FOLKENS JU RAUH W CLEMENS R
Citation: Hj. Schmitt et al., EFFICACY OF ACELLULAR PERTUSSIS-VACCINE IN EARLY-CHILDHOOD AFTER HOUSEHOLD EXPOSURE, JAMA, the journal of the American Medical Association, 275(1), 1996, pp. 37-41
CLINICAL-EXPERIENCE OF A TRICOMPONENT ACELLULAR PERTUSSIS-VACCINE COMBINED WITH DIPHTHERIA AND TETANUS TOXOIDS FOR PRIMARY VACCINATION IN 22,505 INFANTS
Authors: SCHMITT HJ SCHUIND A KNUF M BEUTEL K SCHULTEWISSERMANN H GAHR M SCHULT R FOLKENS J RAUH W BOGAERTS H BORK HL CLEMENS R
Citation: Hj. Schmitt et al., CLINICAL-EXPERIENCE OF A TRICOMPONENT ACELLULAR PERTUSSIS-VACCINE COMBINED WITH DIPHTHERIA AND TETANUS TOXOIDS FOR PRIMARY VACCINATION IN 22,505 INFANTS, The Journal of pediatrics, 129(5), 1996, pp. 695-701
OVERVIEW OF THE CLINICAL DEVELOPMENT OF A DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS-VACCINE
Authors: BOGAERTS H CAPIAU C HAUSER P MARESCHAL JC MELOT V SIMONS D
Citation: H. Bogaerts et al., OVERVIEW OF THE CLINICAL DEVELOPMENT OF A DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS-VACCINE, The Journal of infectious diseases, 174, 1996, pp. 276-280
ACELLULAR PERTUSSIS VACCINES - THE RATIONALE FOR AN EFFICACY TRIAL INGERMANY
Authors: SCHMITT HJ SCHUIND A KNUF M ZEPP F BEUTEL K VONKONIG CHW NEISS A BOCK HL BOGAERTS H CLEMENS R
Citation: Hj. Schmitt et al., ACELLULAR PERTUSSIS VACCINES - THE RATIONALE FOR AN EFFICACY TRIAL INGERMANY, The Journal of infectious diseases, 174, 1996, pp. 287-290
IMMUNOGENICITY AND SAFETY OF A LIVE ATTENUATED VARICELLA VACCINE (OKASB BIO) IN HEALTHY-CHILDREN/
Authors: MEURICE F DEBOUVER JL VANDEVOORDE D WOODS S BOGAERTS H
Citation: F. Meurice et al., IMMUNOGENICITY AND SAFETY OF A LIVE ATTENUATED VARICELLA VACCINE (OKASB BIO) IN HEALTHY-CHILDREN/, The Journal of infectious diseases, 174, 1996, pp. 324-329
PRIMARY VACCINATION OF INFANTS WITH A COMBINED DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS-HEPATITIS-B VACCINE
Authors: KANRA G CEYHAN M ECEVIT Z BOGAERTS H DEGRAVE D HAUSER P DESMONS P
Citation: G. Kanra et al., PRIMARY VACCINATION OF INFANTS WITH A COMBINED DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS-HEPATITIS-B VACCINE, The Pediatric infectious disease journal, 14(11), 1995, pp. 998-1000
SYMPTOMS AND COMPLICATIONS OF PERTUSSIS IN ADULTS
Authors: POSTELSMULTANI S SCHMITT HJ VONKONIG CHW BOCK HL BOGAERTS H
Citation: S. Postelsmultani et al., SYMPTOMS AND COMPLICATIONS OF PERTUSSIS IN ADULTS, Infection, 23(3), 1995, pp. 139-142
STUDY OF PERTUSSIS VACCINES IN INFANTS - COMPARISON OF RESPONSE TO ACELLULAR PERTUSSIS DTP VACCINES CONTAINING 25 MU-G OF FHA AND EITHER 25OR 8 MU-G OF PT WITH RESPONSE TO WHOLE-CELL PERTUSSIS DTP VACCINE
Authors: VANURA H JUST M AMBROSCH F BERGER RM BOGAERTS H WYNEN J VANDEVOORDE D WIEDERMANN G
Citation: H. Vanura et al., STUDY OF PERTUSSIS VACCINES IN INFANTS - COMPARISON OF RESPONSE TO ACELLULAR PERTUSSIS DTP VACCINES CONTAINING 25 MU-G OF FHA AND EITHER 25OR 8 MU-G OF PT WITH RESPONSE TO WHOLE-CELL PERTUSSIS DTP VACCINE, Vaccine, 12(3), 1994, pp. 210-214
ANTIBODIES TO FILAMENTOUS HEMAGGLUTININ OF BORDETELLA-PERTUSSIS AND PROTECTION AGAINST WHOOPING-COUGH IN SCHOOLCHILDREN
Authors: HE QS VILJANEN MK OLANDER RM BOGAERTS H DEGRAVE D RUUSKANEN O MERTSOLA J
Citation: Qs. He et al., ANTIBODIES TO FILAMENTOUS HEMAGGLUTININ OF BORDETELLA-PERTUSSIS AND PROTECTION AGAINST WHOOPING-COUGH IN SCHOOLCHILDREN, The Journal of infectious diseases, 170(3), 1994, pp. 705-708
ACELLULAR PERTUSSIS DIPHTHERIA-TETANUS-PERTUSSIS VACCINE CONTAINING SEPARATELY PURIFIED PERTUSSIS TOXOID, FILAMENTOUS HEMAGGLUTININ AND 69 KDA OUTER-MEMBRANE PROTEIN AS A BOOSTER IN CHILDREN
Authors: KANRA G CEYHAN M VANDEVOORDE D BOGAERTS H
Citation: G. Kanra et al., ACELLULAR PERTUSSIS DIPHTHERIA-TETANUS-PERTUSSIS VACCINE CONTAINING SEPARATELY PURIFIED PERTUSSIS TOXOID, FILAMENTOUS HEMAGGLUTININ AND 69 KDA OUTER-MEMBRANE PROTEIN AS A BOOSTER IN CHILDREN, European journal of pediatrics, 152(6), 1993, pp. 478-483
Risultati: 1-15 |